CIK 0001285819 · Non-accelerated filer<br>Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 911663741
- Phone
- 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,114,339
- in 5 filings, $626K under 10b5-1 plans
Net −$2,114,339. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-06 | Bumol Thomas F. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-04-25 | Demopulos Gregory A MD Chairman, CEO & President | Grant or award · Stock Option (right to buy) | +725,000 | 725,000 | ||
| 2024-04-25 | JACOBSEN MICHAEL A VP, Finance & CAO | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-04-25 | Cancelmo Peter B VP, General Counsel | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-11-17 | Demopulos Gregory A MD Chairman, CEO & President | Purchase | +15,000 | $1.68 | $25K | 123,945 |
| 2023-11-15 | Demopulos Peter A MD Director | Purchase | +10,000 | $1.53 | $15K | 208,516 |
| 2023-11-14 | Demopulos Gregory A MD Chairman, CEO & President | Grant or award | +25,000 | $1.44 | $36K | 108,945 |
| 2023-11-13 | Demopulos Gregory A MD Chairman, CEO & President | Grant or award | +37,500 | $1.29 | $48K | 83,945 |
| 2023-09-22 | Demopulos Gregory A MD Chairman, CEO & President | Grant or award · Stock Option (right to buy) | +715,000 | 715,000 | ||
| 2023-09-22 | JACOBSEN MICHAEL A VP, Finance & CAO | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-09-22 | Cancelmo Peter B VP, General Counsel | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-09-12 | Bumol Thomas F. Director | Grant or award | +10,000 | $3.31 | $33K | 10,000 |
| 2023-06-23 | HANISH ARNOLD C Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-06-23 | Hood Leroy E. MD PhD Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-06-23 | Demopulos Peter A MD Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-06-23 | Shah Rajiv Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-06-23 | Bumol Thomas F. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-06-23 | Cable Thomas J. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-05-22 | HANISH ARNOLD C Director | Option exercise | +5,000 | $5.30 | $27K | 5,000 |
| 2023-05-22 | HANISH ARNOLD C Director | Sale | −5,000 | $6.46 | $32K | 0 |
Page 5 of 9 · 178 trades